| 注册
首页|期刊导航|护理学报|衰弱对癌症患者治疗相关临床结局影响的范围综述

衰弱对癌症患者治疗相关临床结局影响的范围综述

赵娇娇 张超 马景双 邢艺迪

护理学报2026,Vol.33Issue(6):42-49,8.
护理学报2026,Vol.33Issue(6):42-49,8.DOI:10.16460/j.issn2097-6569.2026.06.042

衰弱对癌症患者治疗相关临床结局影响的范围综述

Impact of frailty on treatment-related clinical outcomes in cancer patients:a scoping review

赵娇娇 1张超 2马景双 1邢艺迪1

作者信息

  • 1. 辽宁中医药大学 护理学院,辽宁 沈阳 110847
  • 2. 临沂市肿瘤医院 妇科二病区,山东 临沂 276000
  • 折叠

摘要

Abstract

Objective To examine the impact of frailty on treatment-related clinical outcomes in cancer patients,and to provide a theoretical basis for interventions targeting frailty in this population.Methods This scoping review was conducted in accordance with the Joanna Briggs Institute(JBI)framework,with the research question defined using the PCC(population,concept,and context)strategy.PubMed,Web of Science,Embase,CINAHL,and the Chinese databases CNKI,Wanfang,and SinoMed were systematically searched for studies on the impact of frailty on treatment-related clinical outcomes in cancer patients,with a retrieval time spanning from data-base inception to March 25,2025.Two reviewers independently screened the literature and extracted data.The extracted information included study design,cancer type/treatment modality,frailty assessment tools and timing,frailty prevalence,and treatment-related clinical outcomes.The included evidence was summarized descriptively.Results Twenty-seven studies were included.Frailty preva-lence ranged from 3.6%to 70.6%,with substantial variation across cancer types,assessment tools,and assessment time points.Existing evidence indicated that frailty was associated with adverse outcomes,including postoperative complications and hospitalization-related outcomes,mortality/survival outcomes,chemotherapy toxicity or treatment tolerance,and diminished quality of life and functional decline.Conclusion Frailty prevalence among cancer patients varies widely and is associated with multiple categories of treatment-related adverse outcomes.Frailty screening and risk-stratified management are recommended during the perioperative period and key phases of systemic therapy.However,due to heterogeneity in assessment tools and populations,further high-quality longitudinal studies are needed to validate its predictive value and to determine optimal assessment strategies.

关键词

癌症/衰弱/治疗相关结局/术后并发症/化疗耐受性/范围综述

Key words

cancer/frailty/treatment-related outcomes/postoperative complication/chemotherapy tolerance/scoping review

分类

医药卫生

引用本文复制引用

赵娇娇,张超,马景双,邢艺迪..衰弱对癌症患者治疗相关临床结局影响的范围综述[J].护理学报,2026,33(6):42-49,8.

基金项目

辽宁省自然科学基金计划项目(2024-BS-137) (2024-BS-137)

护理学报

2097-6569

访问量0
|
下载量0
段落导航相关论文